Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer


Tonyali O., Benekli M., Berk V., Coskun U., ÖZKAN M. , Yildiz R., ...More

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.139, no.6, pp.981-986, 2013 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 139 Issue: 6
  • Publication Date: 2013
  • Doi Number: 10.1007/s00432-013-1409-1
  • Title of Journal : JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • Page Numbers: pp.981-986

Abstract

Combinations of trastuzumab with paclitaxel or capecitabine are effective therapies in human epidermal growth factor 2 (HER2)-positive metastatic breast cancer (MBC). This retrospective study evaluated the efficacy and toxicity of trastuzumab and paclitaxel plus capecitabine in the first-line therapy for patients with HER2-positive MBC.